1
|
Ma X, Yang S, Zhang T, Wang S, Yang Q, Xiao Y, Shi X, Xue P, Kang Y, Liu G, Sun ZJ, Xu Z. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy. Acta Pharm Sin B 2022; 12:451-466. [PMID: 35127398 PMCID: PMC8800001 DOI: 10.1016/j.apsb.2021.05.016] [Citation(s) in RCA: 49] [Impact Index Per Article: 24.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Revised: 03/28/2021] [Accepted: 04/25/2021] [Indexed: 12/24/2022] Open
Abstract
The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death (ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumor microenvironment (ITM). However, the therapeutic effectiveness has been restricted by inferior drug bioavailability. Herein, we reported a universal bioresponsive doxorubicin (DOX)-based nanogel to achieve tumor-specific co-delivery of drugs. DOX-based mannose nanogels (DM NGs) was designed and choosed as an example to elucidate the mechanism of combined chemo-immunotherapy. As expected, the DM NGs exhibited prominent micellar stability, selective drug release and prolonged survival time, benefited from the enhanced tumor permeability and prolonged blood circulation. We discovered that the DOX delivered by DM NGs could induce powerful anti-tumor immune response facilitated by promoting ICD. Meanwhile, the released mannose from DM NGs was proved as a powerful and synergetic treatment for breast cancer in vitro and in vivo, via damaging the glucose metabolism in glycolysis and the tricarboxylic acid cycle. Overall, the regulation of tumor microenvironment with DOX-based nanogel is expected to be an effectual candidate strategy to overcome the current limitations of ICD-based immunotherapy, offering a paradigm for the exploitation of immunomodulatory nanomedicines.
Collapse
Key Words
- 5-ALA, 5-aminolevulinic acid
- 5-FU, 5-fluorouracil
- ALKP, alkaline phosphatase
- ALT, alanine aminotransferase
- APCs, antigen-presenting cells
- AST, aminotransferase
- ATP, adenosine triphosphate
- AUC, area under curves
- Bioresponsive
- CLSM, confocal laser scanning microscope
- CPT-11, irinotecan
- CRE, creatinine
- CRT, calreticulin
- Ce6, chlorin e6
- Chemotherapy
- DAMPs, damage-associated molecular patterns
- DCs, dendritic cells
- DDSs, drug delivery systems
- DLN, draining lymph nodes
- DM NGs, doxorubicin-based mannose nanogel
- DOC, docetaxel
- DOX, doxorubicin
- DTT, d,l-dithiothreitol
- Doxorubicin
- FCM, flow cytometry
- FDA, Fluorescein diacetate
- GEM, gemcitabine
- GSH, glutathione
- H&E, hematoxylin-eosin
- HCPT, 10-hydroxy camptothecin
- HCT, hematocrit
- HGB, hemoglobin concentration
- HMGB1, high migrating group box 1
- ICB, immune checkpoint blockade
- ICD, immunogenic cell death
- ICG, indocyanine Green
- IHC, immunohistochemistry
- ITM, immunosuppressive tumor microenvironment
- Immunogenic cell death
- Immunotherapy
- LDH, lactate dehydrogenase
- LYM, lymphocyte ratio
- MAN, mannose
- MCHC, mean corpuscular hemoglobin concentration
- MCSs, multicellular spheroids
- MFI, mean fluorescence intensity
- MPV, mean platelet volume
- Mannose
- NGs, nanogels
- Nanogel
- OXA, oxaliplatin
- P18, purpurin 18
- PDI, polydispersity index
- PLT, platelets
- PTX, paclitaxel
- Prodrug
- RBC, red blood cell count
- RDW, variation coefficient of red blood cell distribution width
- TAAs, tumor-associated antigens
- TAM, tumor-associated macrophages
- TGF-β, transforming growth factor-β
- TMA, tissue microarrays
- TME, tumor microenvironment
- Urea, urea nitrogen
- WBC, white blood cell count
- irAEs, immune-related adverse events
Collapse
Affiliation(s)
- Xianbin Ma
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest University, Chongqing 400715, China
| | - Shaochen Yang
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - Tian Zhang
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest University, Chongqing 400715, China
| | - Shuo Wang
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - Qichao Yang
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - Yao Xiao
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
| | - Xiaoxiao Shi
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China
| | - Peng Xue
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest University, Chongqing 400715, China
| | - Yuejun Kang
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest University, Chongqing 400715, China
| | - Gang Liu
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China
- Corresponding authors. Tel./fax: +86 23 68253792 (Zhigang Xu); +86 27 87686108 (Zhijun Sun); +86 592 2880648 (Gang Liu).
| | - Zhi-Jun Sun
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
- Corresponding authors. Tel./fax: +86 23 68253792 (Zhigang Xu); +86 27 87686108 (Zhijun Sun); +86 592 2880648 (Gang Liu).
| | - Zhigang Xu
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest University, Chongqing 400715, China
- Corresponding authors. Tel./fax: +86 23 68253792 (Zhigang Xu); +86 27 87686108 (Zhijun Sun); +86 592 2880648 (Gang Liu).
| |
Collapse
|
2
|
Sun Y, Zhao D, Wang G, Wang Y, Cao L, Sun J, Jiang Q, He Z. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B 2020; 10:1382-1396. [PMID: 32963938 PMCID: PMC7488364 DOI: 10.1016/j.apsb.2020.01.004] [Citation(s) in RCA: 133] [Impact Index Per Article: 33.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2019] [Revised: 11/12/2019] [Accepted: 11/27/2019] [Indexed: 12/12/2022] Open
Abstract
Hypoxia, a salient feature of most solid tumors, confers invasiveness and resistance to the tumor cells. Oxygen-consumption photodynamic therapy (PDT) suffers from the undesirable impediment of local hypoxia in tumors. Moreover, PDT could further worsen hypoxia. Therefore, developing effective strategies for manipulating hypoxia and improving the effectiveness of PDT has been a focus on antitumor treatment. In this review, the mechanism and relationship of tumor hypoxia and PDT are discussed. Moreover, we highlight recent trends in the field of nanomedicines to modulate hypoxia for enhancing PDT, such as oxygen supply systems, down-regulation of oxygen consumption and hypoxia utilization. Finally, the opportunities and challenges are put forward to facilitate the development and clinical transformation of PDT.
Collapse
Key Words
- 3O2, molecular oxygen
- APCs, antigen-presenting cells
- AQ4N, banoxantrone
- CaO2, calcium dioxide
- Cancer
- Ce6, chlorin e6
- CeO2, cerium oxide
- DC, dendritic cells
- DDS, drug delivery system
- DOX, doxorubicin
- EPR, enhanced permeability and retention
- FDA, U.S. Food and Drug Administration
- H2O, water
- H2O2, hydrogen peroxide
- HIF, hypoxia-inducible factor
- HIF-1α, hypoxia-inducible factor-1α
- HSA, human serum albumin
- Hb, hemoglobin
- Hypoxia
- MB, methylene blue
- MDR1, multidrug resistance 1
- MDSC, myeloid derived suppressive cells
- Mn-CDs, magnetofluorescent manganese-carbon dots
- MnO2, manganese dioxide
- NMR, nuclear magnetic resonance
- Nanomedicine delivery systems
- O2.−, superoxide anion
- OH., hydroxyl radical
- Oxygen
- PDT, photodynamic therapy
- PFC, perfluorocarbon
- PFH, perfluoroethane
- PS, photosensitizers
- Photodynamic therapy
- RBCs, red blood cells
- ROS, reactive oxygen species
- TAM, tumor-associated macrophages
- TPZ, tirapazamine
Collapse
Affiliation(s)
- Yixin Sun
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Dongyang Zhao
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Gang Wang
- School of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China
| | - Yang Wang
- School of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China
| | - Linlin Cao
- Department of Pharmaceutics, the Second Hospital of Dalian Medical University, Dalian 116023, China
| | - Jin Sun
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Qikun Jiang
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Zhonggui He
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
| |
Collapse
|